Laninamivir is a potent neuraminidase inhibitor used for the treatment and prophylaxis of both influenza A and influenza B viral infections. In pharmaceutical research and development, maintaining rigorous… Read more

![Chemical structure of (3aR,4R,7aR)-3a,7a-Dihydro-4-[(S)-hydroxy[(4R)-2-oxo-1,3-dioxolan-4-yl]methyl]-2-methyl-4H-pyrano[3,4-d]oxazole-6-carboxylic acid methyl ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1072449-84-3-3aR4R7aR-3a7a-Dihydro-4-S-hydroxy4R-2-oxo-13-dioxolan-4-ylmethyl-2-methyl-4H-pyrano34-doxazole-6-carboxylic-acid-methyl-ester.png&w=3840&q=75)






Laninamivir is a potent neuraminidase inhibitor used for the treatment and prophylaxis of both influenza A and influenza B viral infections. In pharmaceutical research and development, maintaining rigorous quality standards is essential, which necessitates the use of high-quality analytical compounds. This category includes a comprehensive range of reference standards, including the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, and various stable isotope labelled compounds. These materials are vital for impurity profiling, method validation, and routine quality control testing. By utilizing these precise reference standards, laboratories can ensure the accuracy of their analytical procedures, enabling the reliable identification and quantification of impurities and metabolites throughout the drug development and manufacturing lifecycle. These analytical tools provide the consistency required for compliance with stringent regulatory requirements in antiviral drug production.